BOT 4.69% 33.5¢ botanix pharmaceuticals ltd

Ann: Permetrex Outperforms Other CBD Topical Products, page-34

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,956 Posts.
    lightbulb Created with Sketch. 79
    Permetrex is actually far more likely to result in revenues than any of the drugs being developed. 

    Even with the positive results so far, no drug development program is guaranteed to result in commercial success.

    However, Permetrex is clearly more effective at delivering new (or existing!) drugs into the skin than direct application alone. 

    Therefore, Permetrex + existing approved drug = much more effective (or cheaper) version of existing drug.

    I say "cheaper" because Permetrex can delivery x5 more drug into the skin than direct application therefore only 1/5th of the drug is required to achieve the same result so manufacturers can re-formulate with lower amounts of active ingredients thereby reducing costs.

    If existing drug manufacturers are not climbing over each other to use Permetrex I would be very surprised and equally I'd be very surprised if some kind of licensing agreement to use Permetrex wasn't far away given this announcement seems to set the record straight on how effective the technology is for BOT themselves.
    Last edited by refresher: 26/02/19
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
0.015(4.69%)
Mkt cap ! $707.4M
Open High Low Value Volume
32.0¢ 34.0¢ 31.5¢ $1.478M 4.506M

Buyers (Bids)

No. Vol. Price($)
5 107150 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 594669 9
View Market Depth
Last trade - 16.10pm 25/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.